- BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
IDrugs : the investigational drugs journal (2004-01-20)
R Todd Reilly
PMID14730469
ZUSAMMENFASSUNG
BioNumerik Pharmacology Inc, Baxter Oncology GmbH (formerly ASTA Medica AG) and Grelan Pharmaceutical Co Ltd are developing BNP-7787 for the potential reduction of toxicity associated with cisplatin and carboplatin treatment in cancer patients.
MATERIALIEN
Produktnummer
Marke
Produktbeschreibung
Mesna Unreinheit D, European Pharmacopoeia (EP) Reference Standard